细胞外小泡
核酸
化学
小RNA
细胞外
微型多孔材料
生物标志物
分析物
多路复用
胞外囊泡
适体
生物传感器
癌症生物标志物
计算生物学
肽核酸
纳米技术
临床诊断
生物物理学
细胞生物学
分子生物学
人体乳房
生物流体
微泡
肽
诊断生物标志物
乳腺癌
癌症治疗
外体
细胞内
荧光
作者
Wookyoung Jang,Chang-Woo Song,Jinhwa Hong,Soon Young Lim,D. W. Moon,Hyeyeon Roh,K. C. Park,Chang‐Soo Han,Ki Wan Bong
出处
期刊:ACS Sensors
[American Chemical Society]
日期:2026-01-28
卷期号:11 (2): 1129-1136
被引量:1
标识
DOI:10.1021/acssensors.5c03052
摘要
Extracellular vesicle (EV)-derived microRNA (miRNA) is a promising biomarker for various diseases, including cancer. However, the current EV-miRNA detection technologies, such as RT-qPCR and microarray, have depended on the complex amplification and labeling processes, which are not preferred for constructing an on-site diagnosis system. Herein, we present an EV-miRNA detection platform utilizing micropore sensing based on peptide nucleic acid (PNA)-functionalized hydrogel barcodes. Based on the low background signal and high affinity to the miRNA of the PNA probes, the breast cancer-related miRNAs (miR-21 and let-7a) can be detected with femtomolar sensitivities (481 and 551 fM) without any amplification and labeling steps by penetrating the target-captured barcodes into the pore and analyzing the electrical signal. By designing the geometrical codes of the particles, the multiplexed detection of miR-21 and let-7a can be implemented with high specificity and practically applicable recovery rates. Finally, we validate the clinical potential of the presented assay by differentiating the expression patterns of the plasma EV-derived miR-21 and let-7a between the breast cancer patients and healthy donors.
科研通智能强力驱动
Strongly Powered by AbleSci AI